Divalproex Sodium Extended-Release Tablets are indicated for treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches. The product will be commercialized from Unichem's Goa Plant.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content